Takeda Pharmaceutical
TAK
$15.07
Share price
-1.76%
Change (1 day)
14.34%
Change (1 year)
Categories
Takeda Pharmaceutical (TAK) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : $48.77 Billion USD
According to Takeda Pharmaceutical's latest financial reports the company's total liabilities are $48.77 Billion USD. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Takeda Pharmaceutical - Total liabilities on balance sheet (from 2008 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-03-31 | $51.74 B | -9.24% |
| 2023-03-31 | $57.01 B | -7.37% |
| 2022-03-31 | $61.55 B | -11.87% |
| 2021-03-31 | $69.84 B | -7.23% |
| 2020-03-31 | $75.28 B | -2.91% |
| 2019-03-31 | $77.54 B | 294.61% |
| 2018-03-31 | $19.65 B | -8.82% |
| 2017-03-31 | $21.55 B | 33.71% |
| 2016-03-31 | $16.11 B | -7.44% |
| 2015-03-31 | $17.41 B | -11.4% |
| 2014-03-31 | $19.65 B | 8.09% |
| 2013-03-31 | $18.18 B | 4.75% |
| 2012-03-31 | $17.35 B | 122.69% |
| 2011-03-31 | $7.79 B | 11.08% |
| 2010-03-31 | $7.01 B | -1.99% |
| 2009-03-31 | $7.15 B | 39.03% |
| 2008-03-31 | $5.14 B | -0.81% |
| 2007-03-31 | $5.19 B | -11.86% |
| 2006-03-31 | $5.89 B | 16.57% |
| 2005-03-31 | $5.05 B | -5.49% |
| 2004-03-31 | $5.34 B | 28.1% |
| 2003-03-31 | $4.17 B | 2.07% |
| 2002-03-31 | $4.08 B | 4.05% |
| 2001-03-31 | $3.92 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $115.56 B | 136.92% | 🇺🇸 USA |
 Sanofi SNY | $62.18 B | 27.48% | 🇫🇷 France |
 Pfizer PFE | $117.39 B | 140.67% | 🇺🇸 USA |
 Novartis NVS | $61.48 B | 26.06% | 🇨🇭 Switzerland |
 Seagen
SGEN | $1.08 B | -97.78% | 🇺🇸 USA |
 Dr. Reddy's Laboratories RDY | $1.82 B | -96.26% | 🇮🇳 India |
 Amgen AMGN | $83.16 B | 70.49% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $60.79 B | 24.64% | 🇬🇧 UK |
 Merck MRK | $66.72 B | 36.79% | 🇺🇸 USA |